Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-06-14
2011-10-18
Olson, Eric S (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S025000
Reexamination Certificate
active
08039601
ABSTRACT:
The novel crystalline and polymorphic forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane have advantageous properties and can be used in pharmaceutical and dermatological compositions.
REFERENCES:
patent: 5712387 (1998-01-01), Scott et al.
patent: 5919768 (1999-07-01), Kogan et al.
patent: 2002/0132220 (2002-09-01), Berens et al.
patent: 2010/0093653 (2010-04-01), Aydt et al.
patent: 2010/0298245 (2010-11-01), Aydt et al.
patent: WO9701335 (1997-01-01), None
patent: WO0129054 (2001-04-01), None
patent: WO2008028966 (2008-03-01), None
patent: WO2010115164 (2010-10-01), None
E. Crockett-Torabi, Selectins and mechanisms of signal transduction, Journal of Leukocyte Biology, 1998, vol. 63, pp. 1-14.
B. Brenner et al., L-Selectin activates the Ras pathway via the tyrosine kinase p56Ick, Proc. Natl. Acad. Sci, USA, 1996, vol. 93, pp. 15376-15381.
Daniel Bock et al., The Role of Selectins During Lung Inflammation and Their Potential Impact for Innovative Therapeutic Strategies, Current Respiratory Medicine Reviews, 2006, vol. 2, pp. 339-354.
Keisuke Okazaki et al., Enhancement of Metastatic Activity of Colon Cancer as Influenced by Expression of Cell Surface Antigens, Journal of Surgical Research, 1998, vol. 78(1), pp. 78-84.
Rodger P. McEver et al., Selectin-carbohydrate interactions during inflammation and metastasis, Glycoconjugate Journal, 1997, vol. 14(5), pp. 585-591.
Rodger P. McEver et al., Perspective Series: Cell Adhesion in Vascular Biology, Role of PSGL-1 Binding to Selctions in Leukocyte Recruitment, J. Clin. Invest., 1997, vol. 100, No. 3, pp. 485-492.
R.P. McEver, 8 Interactions of Selectins with PSGL-1 and Other Ligands, Ernst Schering Res. Found. Workshop, 2004, vol. 44, pp. 137-147.
Gabriela Constantin, The Identification of PSGL-1 as a central proadhesive molecule could help in the design and testing of a more selective therapy to modify the clinical outcome of various inflammatory diseases in humans. PSGL-1 as a Novel Therapeutic Target, Drug News Perspective, 2004, vol. 17(9), pp. 579-586.
Annette M. Muller et al., Heterogeneous expression of cell adhesion molecules by endothelial cells in ARDS, Journal of Pathology, 2002, vol. 198(2), pp. 270-275.
Antonio Di Stefano et al., Upregulation of Adhesion Molecules in the Bronchial Mucosa of Subjects with Chronic Obstructive Bronchitis, Am. J. Respir. Crit. Care. Med., 1994, vol. 149(3), pp. 803-810.
Satomi Terajima et al., An important role of tumor necrosis factor-a in the induction of adhesion molecules in psoriasis, Arch. Dermatol. Res., 1998, vol. 290, pp. 246-252.
Paolo U. Giacomoni et al., A mechanistic model for the aging of human skin, Micron, 2004, vol. 35, pp. 179-184.
P.U. Giacomoni et al., Factors of skin ageing share common mechanisms, Biogerontology, 2004, vol. 2, pp. 219-229.
Scott, Ian L. et al., Stereospecific alpha.-D-mannosylation, Carbohydrate Research, 1999, vol. 317 (1-4), pp. 210-216.
Timothy P. Kogen et al., Novel Synthetic Inhibitors of Selectin-Mediated Cell Adhesion: Synthesis of 1,6-Bis[3-(3-carboxymethylphenyl)-4(2-a-D-mannopyranosloxy) phenyl]hexane (TBC1269), Journal of Medicinal Chemistry, 1998, vol. 41, pp. 1099-1111.
International Search Report (Form PCT/ISA/210) issued in the corresponding application No. PCT/EP2007/059410, completed Oct. 26, 2007 and mailed on Jan. 18, 2008.
Kogen, Timothy P. et al., “Novel Synthetic Inhibitors of Selectin-Mediated Cell Adhesion: Synthesis of 1,6-Bis[3-(3-carboxymethylphenyl)-4(2-a-D-mannopyranosloxy)phenyl]hexane (TBC1269),” Journal of Medicinal Chemistry, 1998, vol. 41, pp. 1099-1111.
Scott, Ian L. et al., “Stereospecific alpha. -D-mannosylation,” Carbohydrate Research, 1999, vol. 317 (1-4), pp. 210-216.
Nemoto, Takashi et al., “Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure,” Kidney International, vol. 60, 2001, pp. 2205-2214.
Jayle, C. et al., “Protective role of selectin ligand inhibition in a large animal model of kidney ischemia-reperfusion injury,” Kidney International, vol. 69, 2006, pp. 1749-1755.
Ulbrich, Holger et al., “Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease,” Trends in Pharmacological Sciences, vol. 24, No. 12, Dec. 2003, pp. 640-647.
Aydt Ewald M.
Kranich Remo
Vollhardt Karin
Wolff Gerhard
J.A. Lindeman & Co., PLLC
Olson Eric S
Revotar Biopharmaceuticals AG
LandOfFree
Crystalline forms of 1,6-Bis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of 1,6-Bis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of 1,6-Bis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4277356